Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-03-08-Speech-2-254-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110308.22.2-254-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"I would like to thank the rapporteur for a very detailed and frank report, which contains many alarming messages. It is beyond doubt that the joint approach of the EU during the pandemic verified the potential of joint action, while also revealing dramatic weaknesses, particularly in the areas of prevention, objective statistics and the purchasing of safe and effective medicines. The EU has twice recently faced the problem of a dangerous viral infection. Not enough has been learned from the experience. I welcome the proposals relating to more stringent testing of the effectiveness of medicines and pressing for objective data collection, and also the interest in protecting all EU citizens regardless of healthcare system. I consider the demand for research and development funding to be of fundamental importance, as well as the rule that pharmaceutical companies will have a consultative role, and not a deciding role. The same applies to studies and tests on vaccination materials and other medicines, which must be drawn up independently of pharmaceutical firms. I also support the demand for more stringent rules for professionals and advisers working for European institutions. The public must be clearly and transparently informed, although in a way which will not cause panic, but will provide qualified and comprehensible information. As the Quaestor jointly responsible for protecting the health of MEPs and European Parliament (EP) employees, I would like to say that our measures in the EP have been effective, but not cheap."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples